Taro Pharmaceutical
TARO
$39.10
Share price
-0.66%
Change (1 day)
11.71%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total assets
Total assets on the balance sheet as of September 2022 : $2.10 B
According to Taro Pharmaceutical's latest financial reports the company's total assets are $2.10 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Taro Pharmaceutical - Total assets on balance sheet (from 2001 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-03-31 | $2.17 B | -9.58% |
| 2021-03-31 | $2.40 B | 2.8% |
| 2020-03-31 | $2.34 B | 9.64% |
| 2019-03-31 | $2.13 B | -12.24% |
| 2018-03-31 | $2.43 B | 6.27% |
| 2017-03-31 | $2.28 B | 4.65% |
| 2016-03-31 | $2.18 B | 25.91% |
| 2015-03-31 | $1.73 B | 35.3% |
| 2014-03-31 | $1.28 B | 16.06% |
| 2013-03-31 | $1.10 B | |
| 2011-12-31 | $0.79 B | 43.02% |
| 2010-12-31 | $0.55 B | -3.38% |
| 2009-12-31 | $0.57 B | 21.73% |
| 2008-12-31 | $0.47 B | -2.12% |
| 2007-12-31 | $0.48 B | 13.81% |
| 2006-12-31 | $0.42 B | -26.65% |
| 2005-12-31 | $0.57 B | -16.91% |
| 2004-12-31 | $0.69 B | 13.03% |
| 2003-12-31 | $0.61 B | 62.31% |
| 2002-12-31 | $0.37 B | 23.42% |
| 2001-12-31 | $0.30 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $187.37 B | 8,791.94% | 🇺🇸 USA |
 Novartis NVS | $112.24 B | 5,226.34% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 9,258.27% | 🇺🇸 USA |
 Merck MRK | $109.16 B | 5,080.14% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $72.58 B | 3,344.46% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $44.00 B | 1,988.28% | 🇮🇱 Israel |